Clinica Cayanga Medical Resources


Clinical Updates


Clinical Updates
Alzheimer's Disease
Arthritis
Benign Prostatic Hypertrophy
Chronic Lymphocytic Leukemia
Depression
Diabetes Mellitus
Dyspepsia
Erectile Dysfunction
Fatty Liver
Gallstone
Hepatitis
Hypertension
Lung Cancer
Mesothelioma
Metabolic Syndrome
Obesity
Prostate Cancer
Stroke
Tinnitus
 
Medical Library
Breaking Medical News
Clinical Tools
Dermatology
Diabetes Corner
Evidence-Based Medicine
Free Medical Books
Free Medical Journal
History Taking and Physical Examination
Medical Journal (popular)
Medical Notes
Medical Organizations
Palm Tools
Medical Physiology (Lecture)
Medical Resources
Medical Search
Online Clinical Calculator
 
 

 

Pseudoephedrine has a minimal effect on BP

 

Clinical Question:
Does pseudoephedrine (Sudafed) increase blood pressure in people or in patients with hypertension?

Bottom Line:
Overall, immediate-release pseudoephedrine produces a small increase in systolic blood pressure (1.5 mmHg) but has no effect on diastolic blood pressure. Sustained-release products do not affect blood pressure. Both types of products increase heart rate to a small degree. Unlike its cousin phenylpropanolamine, pseudoephedrine rarely causes large increases in blood pressure, although its effect on blood pressure is dose-related and a marked effect could occur with overdose.

Reference:
Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate. Arch Intern Med 2005;165:1686-94.

Study Design:
Meta-analysis (randomized controlled trials)

Synopsis:
Oral pseudoephedrine is commonly used to treat symptoms of rhinitis and rhinorrhea, but its effect on blood pressure (BP) and heart rate (HR) remains uncertain. We assessed whether pseudoephedrine causes clinically meaningful elevations in HR or BP. We searched MEDLINE, EMBASE, and the Cochrane Library for English-language, randomized placebo-controlled trials of oral pseudoephedrine treatment in adults. The primary data extracted were systolic BP (SBP), diastolic BP (DBP), and HR. Study quality was assessed using the methods of Jadad, and data were synthesized using a random-effects model and weighted mean differences. Twenty-four trials had extractable vital sign information (45 treatment arms; 1285 patients). Pseudoephedrine caused a small but significant increase in SBP (0.99, mm Hg; 95% CI, 0.08 to 1.90) and HR (2.83 beats/min; 95% CI, 2.0 to 3.6), with no effect on DBP (0.63 mm Hg, 95% CI, -0.10 to 1.35). The effect in patients with controlled hypertension demonstrated an SBP increase of similar magnitude (1.20 mm Hg; 95% CI, 0.56 to 1.84 mm Hg). Higher doses and immediate-release preparations were associated with greater BP increases. Studies with more women had less effect on BP or HR. Shorter duration of use was associated with greater increases in SBP and DBP.

 

 

   

Home | Introduction | Scheduling a Visit| Laboratory Work Reaching Us | Map to our Office | About the Doctors

 

 

 ©2005 Clinica Cayanga. All rights reserved.